iBio (IBIO) EBITDA Margin Growth (3y) (2014 - 2024)
iBio (IBIO) EBITDA Margin Growth (3y) (2014 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.03 Bn | 467.24 Bn | 1.35 Bn | 9,942.00 |
| 5 | Vertex Pharmaceuticals | 122.09 Bn | 114.84 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.99 Bn | 50.80 Bn | 1.41 Bn | -623.00 |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 6,993.00 |
| 10 | iBio | 167.44 Mn | 167.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -2,560.00 |
| Sep 30, 2023 | -851,722.00 |
| Mar 31, 2022 | 33,826.00 |
| Sep 30, 2021 | 255,754.00 |
| Jun 30, 2021 | 241,386.00 |
| Mar 31, 2021 | 353,664.00 |
| Dec 31, 2020 | 116,966.00 |
| Sep 30, 2020 | 106,614.00 |
| Jun 30, 2020 | 236,365.00 |
| Mar 31, 2020 | 640,450.00 |
| Dec 31, 2019 | 342,856.00 |
| Sep 30, 2019 | -123,315.00 |
| Jun 30, 2019 | 49,164.00 |
| Mar 31, 2019 | 9,518.00 |
| Dec 31, 2018 | 106,535.00 |
| Sep 30, 2018 | -764,465.00 |
| Jun 30, 2018 | -373,626.00 |
| Mar 31, 2018 | -399,454.00 |
| Dec 31, 2017 | -178,592.00 |
| Sep 30, 2017 | -258,202.00 |